>
Switch to:

Cara Therapeutics EV-to-EBIT

: 231.45 (As of Today)
View and export this data going back to 2014. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cara Therapeutics's Enterprise Value is $1,246.3 Mil. Cara Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $5.4 Mil. Therefore, Cara Therapeutics's EV-to-EBIT for today is 231.45.

NAS:CARA' s EV-to-EBIT Range Over the Past 10 Years
Min: -114.54   Med: -6.1   Max: 245.18
Current: 231.45

-114.54
245.18

During the past 10 years, the highest EV-to-EBIT of Cara Therapeutics was 245.18. The lowest was -114.54. And the median was -6.10.

NAS:CARA's EV-to-EBIT is ranked lower than
94% of the 264 Companies
in the Biotechnology industry.

( Industry Median: 31.29 vs. NAS:CARA: 231.45 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cara Therapeutics's Enterprise Value for the quarter that ended in Dec. 2020 was $578.9 Mil. Cara Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $5.4 Mil. Cara Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was 0.93%.


Cara Therapeutics EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Cara Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.34 -5.16 -4.56 -5.39 107.51

Cara Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.39 -4.23 0.00 0.00 107.51

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Cara Therapeutics EV-to-EBIT Distribution

* The bar in red indicates where Cara Therapeutics's EV-to-EBIT falls into.



Cara Therapeutics EV-to-EBIT Calculation

Cara Therapeutics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1246.337/5.385
=231.45

Cara Therapeutics's current Enterprise Value is $1,246.3 Mil.
Cara Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was -30.001 (Mar. 2020 ) + -25.884 (Jun. 2020 ) + -17.02 (Sep. 2020 ) + 78.29 (Dec. 2020 ) = $5.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Cara Therapeutics  (NAS:CARA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cara Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2020 ) =EBIT / Enterprise Value (Q: Dec. 2020 )
=5.385/578.916386
=0.93 %

Cara Therapeutics's Enterprise Value for the quarter that ended in Dec. 2020 was $578.9 Mil.
Cara Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was -30.001 (Mar. 2020 ) + -25.884 (Jun. 2020 ) + -17.02 (Sep. 2020 ) + 78.29 (Dec. 2020 ) = $5.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Cara Therapeutics EV-to-EBIT Related Terms


Cara Therapeutics EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)